Real-world use of tisagenlecleucel in children and young adults with relapsed or refractory B-cell lymphomas

Affiliations

• ¹ Division of Oncology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
• ² Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH.
• ³ Department of Hematology, Oncology, Neuro-Oncology & Stem Cell Transplantation, Ann & Robert Lurie Children's Hospital of Chicago, Chicago, IL.
• ⁴ Division of Hematology, Oncology and Bone Marrow Transplant, Department of Pediatrics, School of Medicine and Public Health, University of Wisconsin, Madison, WI.
• ⁵ University of Wisconsin Carbone Cancer Center, Madison, WI.
• ⁶ Division of Hematology/Oncology/Blood and Marrow Transplantation, Department of Pediatrics, Medical College of Wisconsin and Children's Wisconsin, Milwaukee, WI.
• ⁷ Division of Oncology, Children's National Hospital, Washington, DC.
• ⁸ Division of Blood and Marrow Transplantation, Children's National Hospital, Washington, DC.
• ⁹ Department of Pediatrics, George Washington School of Medicine and Health Sciences, Washington, DC.
• ¹⁰ Division of Hematology and Oncology, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA.
• ¹¹ Division of Hematology-Oncology, Rady Children's Hospital, San Diego, CA.
• ¹² Department of Pediatrics, University of California San Diego, La Jolla, CA.
• ¹³ Department of Pediatrics, University of Arizona Cancer Center, University of Arizona, Tucson, AZ.
• ¹⁴ Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR.
• ¹⁵ Pediatric Blood and Marrow Transplant and Cellular Therapy Program, Helen DeVos Children's Hospital, Department of Pediatrics, Michigan State University College of Human Medicine, Grand Rapids, MI.
• ¹⁶ Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA.